Enzyme-inducing effects of bicalutamide in mouse, rat and dog

Xenobiotica

Volumn 28, Issue 5, 1998, Pages 465-478

  McKillop, D ^a   Butters, C J ^a   Hill, S J ^a   Simons, P J ^a   Edwards, T L ^a   Doughty, S E ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXYCOUMARIN DEETHYLASE; ALDRIN EPOXIDASE; ANTIANDROGEN; BICALUTAMIDE; CYTOCHROME P450; ENZYME; ERYTHROMYCIN N DEMETHYLASE; ETHOXYRESORUFIN DEETHYLASE; PENTOXYRESORUFIN DEALKYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; LIVER; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STRAIN DIFFERENCE;

7-ALKOXYCOUMARIN O-DEALKYLASE; ADMINISTRATION, ORAL; ANDROGEN ANTAGONISTS; ANILIDES; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BILE; CELLS, CULTURED; CYTOCHROME P-450 CYP2B1; CYTOCHROME P-450 ENZYME SYSTEM; DOGS; ENZYME INDUCTION; FECES; FEMALE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; NADPH-FERRIHEMOPROTEIN REDUCTASE; RATS; RATS, INBRED STRAINS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031864034     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982598239399     Document Type: Article

References (28)

1. BOYLE, G. W., MCKILLOP, D., PHILLIPS, P. J., HARDING, J. R., PICKFORD, R. and MCCORMICK, A. D. 1993, Metabolism of Casodex in laboratory animals. Xenobiotica, 23, 781-798.
2. BRECKENRIDGE, A., 1987, Enzyme induction in man. Clinical aspects - an overview. In Enzyme Induction in Man, edited by E. A. Sotaniemi and R. O. Pelkonen (London: Taylor & Francis), pp. 201-209.
3. COCKSHOTT, I. D., COOPER, K. J., SWEETMORE, D. S., BLACKLOCK, N. J. and DENIS, L., 1990, The pharmacokinetics of Casodex in prostate cancer patients after single and multiple dosing. European Urology, 18 (suppl. 3), 10-17.
4. COCKSHOTT, I. D., PLUMMER, G. F., COOPER, K. J. and WARWICK, M. J., 1991, The pharmacokinetics of Casodex in laboratory animals. Xenobiotica, 21, 1347-1355.
5. CORCOS, L., 1992, Phenobarbital and dexamethasone induce expression of cytochrome P450 genes from subfamilies IIB, IIC and IIIA in mouse liver. Drug Metabolism and Disposition, 20, 797-801.
6. DIAMOND, S., RAKESTRAW, D., O'NEIL, J., LAM, G. N. and CHRIST, D. D., 1994, Induction of cytochromes P450 2B and 3A in mice following the dietary administration of the novel cognitive enhancer linopirdine. Drug Metabolism and Disposition, 22, 65-73.
7. FORKERT, P. G., MIREHOUSE-BROWN, P., PARK, S. S. and GELBOIN, H. H., 1988, Distribution and induction sites of phenobarbital-and 3-methylcholanthrene-inducible cytochromes P450 in murine liver: immunohistochemical localisation with monoclonal antibodies. Molecular Pharmacology, 34, 736-743.
8. FURR, B. J. A., 1989, Casodex (ICI 176,334) - a new, pure, peripherally selective antiandrogen: preclinical studies. Hormone Research, 32 (Suppl 1), 69-76.
9. FURR, B. J. A., BLACKLEDGE, G. and COCKSHOTT, I. D., 1996, Casodex, preclinical and clinical studies. In Hormone-Dependent Cancer, edited by J. R. Pasqualini and B. S. Katzenellenbogen (New York: Marcel Dekker), pp. 397-424.
10. HOSTELTER, K. A., WRIGHTON, S. A., MOLOWA, D. T., THOMAS, P. E., LEVIN, W. and GUZELIAN, P. S., 1989, Coinduction of multiple hepatic cytochrome P450 proteins and their mRNAs in rats treated with imidazole antimycotic agents. Molecular Pharmacology, 35, 279-285.
11. ISWARAN, T. J., IMAI, M., BETTON, G. R. and SIDDAL, R. A., 1977, An overview of animal toxicology studies with bicalutamide (ICI 176,334). Journal of Toxicological Sciences, 22, 75-88.
12. KAISARY, A., KLARSKOV, P. and MCKILLOP, D., 1996, Absence of enzyme induction in prostate cancer patients receiving Casodex (bicalutamide). Anti-Cancer Drugs, 7, 54-59.
13. LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature, 227, 680-685.
14. LUMLEY, J. S. P., GREEN, C. J., LEAR, P. and ANGELL-JAMES, J. E., 1990, Essentials of Experimental Surgery (London: Butterworths).
15. MCCLAIN, R. M., 1989, The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicologic Pathology, 17, 294-306.
16. MCKILLOP, D., 1985, Effects of phenobarbitone and β-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog. Biochemical Pharmacology, 34, 3137-3142.
17. MCKILLOP, D., BOYLE, G. W., COCKSHOTT, I. D., JONES, D. C., PHILLIPS, P. J. and YATES, R. A., 1993, Metabolism and enantioselective pharmacokinetics of Casodex in man. Xenobiotica, 23, 1241-1253.
18. MCKILLOP, D., SIMONS, P. J., COCKSHOTT, I. D., HILL, S. J., HARDING, J. R., COOPER, K. J. and JONES, D. C., 1995, Enantioselective metabolism and pharmacokinetics of Casodex in the male rat. Xenobiotica, 25, 623-634.
19. NEWMAN, S. L. and GUZELIAN, P. S., 1983, Identification of the cyanopregnenolone-inducible form of hepatic cytochrome P450 as a catalyst of aldrin epoxidation. Biochemical Pharmacology, 32, 1529-1531.
20. PARKINSON, A., CLEMENT, R. P., CASCIANO, C. N. and CAYEN, M. N., 1992, Evaluation of loratidine as an inducer of liver microsomal cytochrome P450 in rats and mice. Biochemical Pharmacology, 43, 2169-2180.
21. PRUEKSARITANONT, T., CORREIA, M. A., RETTIE, A. E., SWINNEY, D. C., THOMAS, P. E. and BENET, L. Z., 1993, Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P450 3A. Drug Metabolism and Disposition, 21, 730-737.
22. RITTER, J. K. and FRANKLIN, M. R., 1987, High magnitude hepatic cytochrome P450 induction by an N-substituted imidazole antimycotic, clotrimazole. Biochemical Pharmacology, 36, 2783-2787.
23. RUSH, W. R., SMITH, S. A., MULVEY, J. H., GRAHAM, D. J. M. and CHAPLIN, M. D., 1987, Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol. Drug Metabolism and Disposition, 15, 571-578.
24. STERNBERGER, L. A., HARDY, P. N. H., CUCULIS, J. J. and MEYER, H. G., 1970, The unlabelled antibody-enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. Histochemical Cytochemistry, 18, 315-333.
25. TOMLINSON, P. W., JEFFERY, D. J. and FILER, C. W., 1981, A novel technique for assessment of biliary secretion and enterohepatic circulation in the unrestrained conscious rat. Xenobiotica, 12, 863-870.
26. TREIMAN, D. M., WILENSKY, A. J., BEN-MENACHEM, K., OJEMANN, L., YERBY, M., BARBER, K. O'L., MCCORMICK, K. B., CEREGHINO, J. J., WHITE, B. G. and SWISHER, K., 1985, Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot study. Epilepsia, 26, 607-611.
27. WOLFF, T. and GUENGERICH, F. P., 1987, Rat liver cytochrome P450 isozymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes. Biochemical Pharmacology, 36, 2581-2588.
28. WHIGHTON, S. A., SCHUETZ, E. G., WATKINS, P. B., MAUREL, P., BARWICK, J., BAILEY, B. S., HARTLE, H. T., YOUNG, B. and GUZELIAN, P., 1985, Demonstration in multiple species of inducible hepatic cytochromes P450 and their mRNAs related to the glucocorticoid-inducible cytochrome P450 of the rat. Molecular Pharmacology, 28, 312-321.